Matthew Keller
Stock Analyst at H.C. Wainwright
(0.13)
# 4,611
Out of 4,690 analysts
95
Total ratings
33.8%
Success rate
-14.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Keller
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SXTP 60 Degrees Pharmaceuticals | Maintained: Hold | n/a | $1.03 | - | 6 | Aug 18, 2026 | |
| GALT Galectin Therapeutics | Reiterated: Buy | $11 | $4.02 | +173.63% | 11 | Aug 14, 2026 | |
| KYNB Kyntra Bio | Reiterated: Buy | $43 | $8.02 | +436.16% | 14 | Aug 14, 2026 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $31 | $1.45 | +2,037.93% | 12 | Aug 14, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $18 | $6.59 | +173.14% | 11 | Aug 7, 2026 | |
| IFRX InflaRx | Reiterated: Buy | $8 | $2.23 | +258.74% | 11 | Aug 6, 2026 | |
| MCRB Seres Therapeutics | Reiterated: Buy | $12 | $5.11 | +134.83% | 3 | Aug 5, 2026 | |
| GRI GRI Bio | Reiterated: Buy | $10 | $1.92 | +420.83% | 9 | May 14, 2026 | |
| PHIO Phio Pharmaceuticals | Reiterated: Buy | $14 | $1.13 | +1,138.94% | 9 | May 8, 2026 | |
| ITRMF Iterum Therapeutics plc | Downgraded: Hold | n/a | $0.000001 | - | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $33.84 | - | 4 | Oct 30, 2025 |
60 Degrees Pharmaceuticals
Aug 18, 2026
Maintained: Hold
Price Target: n/a
Current: $1.03
Upside: -
Galectin Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $11
Current: $4.02
Upside: +173.63%
Kyntra Bio
Aug 14, 2026
Reiterated: Buy
Price Target: $43
Current: $8.02
Upside: +436.16%
Acurx Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: $31
Current: $1.45
Upside: +2,037.93%
Gyre Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $6.59
Upside: +173.14%
InflaRx
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $2.23
Upside: +258.74%
Seres Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $12
Current: $5.11
Upside: +134.83%
GRI Bio
May 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.92
Upside: +420.83%
Phio Pharmaceuticals
May 8, 2026
Reiterated: Buy
Price Target: $14
Current: $1.13
Upside: +1,138.94%
Iterum Therapeutics plc
Mar 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: -
Oct 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $33.84
Upside: -